Search research articles
Contact Us
Filters
Showing results (51-60 of 170) with videos related to
Page
of 17
Sort By:
Plos One
|
November 27, 2024
An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape
Angelyn Anton, Ryan Hutchinson, Christopher M Hovens, et al.
Internal Medicine Journal
|
February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre study
Edmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
JCO Global Oncology
|
March 6, 2026
Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts
William Harris, Sarah Shirley, Elizabeth Liow, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2018
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumors
Ben Tran, Richard D Carvajal, Aurelien Marabelle, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 11, 2018
Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer
Anis A Hamid, Kaspar Willson, Andrew D Vincent, et al.
Asia-Pacific Journal of Clinical Oncology
|
June 26, 2024
Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012-2022
Nadia Hitchen, Adel Shahnam, Sathya Manoharan, et al.
Basic and Clinical Andrology
|
September 2, 2024
Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis
Grace Y Kim, Ciara Conduit, Sophie O'Haire, et al.
Cell Reports. Medicine
|
October 18, 2023
A phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab in patients with advanced solid tumors
Sophia Frentzas, Hui K Gan, Rasha Cosman, et al.
BJU International
|
July 25, 2015
Patterns of care for metastatic renal cell carcinoma in Australia
Daphne Day, Yada Kanjanapan, Edmond Kwan, et al.
Investigational New Drugs
|
May 17, 2018
A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers
Aflah Roohullah, Adam Cooper, Anna J Lomax, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 170) with videos related to
Sort By:
Page
of 17
Plos One
|
November 27, 2024
An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape
Angelyn Anton, Ryan Hutchinson, Christopher M Hovens, et al.
Internal Medicine Journal
|
February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre study
Edmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
JCO Global Oncology
|
March 6, 2026
Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts
William Harris, Sarah Shirley, Elizabeth Liow, et al.
Journal for Immunotherapy of Cancer
|
September 27, 2018
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumors
Ben Tran, Richard D Carvajal, Aurelien Marabelle, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 11, 2018
Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer
Anis A Hamid, Kaspar Willson, Andrew D Vincent, et al.
Asia-Pacific Journal of Clinical Oncology
|
June 26, 2024
Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012-2022
Nadia Hitchen, Adel Shahnam, Sathya Manoharan, et al.
Basic and Clinical Andrology
|
September 2, 2024
Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis
Grace Y Kim, Ciara Conduit, Sophie O'Haire, et al.
Cell Reports. Medicine
|
October 18, 2023
A phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab in patients with advanced solid tumors
Sophia Frentzas, Hui K Gan, Rasha Cosman, et al.
BJU International
|
July 25, 2015
Patterns of care for metastatic renal cell carcinoma in Australia
Daphne Day, Yada Kanjanapan, Edmond Kwan, et al.
Investigational New Drugs
|
May 17, 2018
A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers
Aflah Roohullah, Adam Cooper, Anna J Lomax, et al.
Page
of 17